Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals stock analysis and opportunity scoring
$3.40
↑ +1.80%
Recursion Pharmaceuticals (RXRX) at a glance
Recursion Pharmaceuticals (RXRX) is a publicly traded company tracked by MKD Intelligence.
RXRX last traded at $3.00 as of 2026-09-01.
MKD Intelligence assigns RXRX a composite opportunity score of 62 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for RXRX is 75 out of 100 (high), where a higher number means greater expected volatility.
Price History
High
$3.56
Low
$3.00
Period
Aug 31 - Jul 31 (22d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 1
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.